Improvement in Cognitive Function as Measured by NeuroTrax in Patients with Relapsing Multiple Sclerosis Treated with Natalizumab: A 2-Year Retrospective Analysis.
作者:
主题词
成年人(Adult);认知障碍(Cognition Disorders);残疾鉴定(Disability Evaluation);女(雌)性(Female);人类(Humans);免疫因子类(Immunologic Factors);男(雄)性(Male);中年人(Middle Aged);多发性硬化, 复发缓解性(Multiple Sclerosis, Relapsing-Remitting);神经心理学测验(Neuropsychological Tests);回顾性研究(Retrospective Studies);时间因素(Time Factors);治疗结果(Treatment Outcome);美国(United States)
DOI
10.1007/s40263-018-0553-1
PMID
30143944
发布时间
2021-01-09
- 浏览7

CNS drugs
1173-1181页
相似文献
- 中文期刊
- 外文期刊
- 学位论文
- 会议论文